Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 221-230 of 270 for

Edit search filters
  1. Long Term Prognosis of Neuroinvasive West Nile Infection

    Rochester, MN

  2. A Study to Evaluate the QuantiFERON-TB Gold-Plus Test for Blood Detection of Tuberculosis without Symptoms

    Rochester, MN

  3. BinaxNow™ Rapid Test

    Rochester, MN

  4. MAGPIES Biorepository

    Rochester, MN

  5. Antibodies against COVID (enrolling by invitation)

    Rochester, MN

  6. A Registry of Antifungal Therapy in Adults with Either Invasive Mucormycosis or Invasive Aspergillosis

    Rochester, MN

  7. BK Virus Immunity in Kidney Transplant

    Rochester, MN

  8. A Study to Evaluate COVID Brain Advanced Imaging Network

    Rochester, MN

  9. COVID-19 (Coronavirus) Pandemic on Health and Healthcare

    Rochester, MN

  10. A Study to Determine Late Outcomes and Immunological Responses in Children With/Without Multisystem Inflammatory Syndrome After SARS-CoV-2

    Rochester, MN

.

Mayo Clinic Footer